Murray Dallan bought SRPT
March 10, 2025 · Form 4 insider transaction
Murray Dallan bought 16,644 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,644
Price
$0.00
Total value
N/A
InsiderMurray Dallan
RoleOfficer
SecurityStock Options (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after16,644
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.